NCT06051656

Brief Summary

Contracture which is defined as a limitation of the maximum passive range of motion due to changes in periarticular soft tissue can contributes to severe pain and increased disabilities. Once contracture is present, management options are very limited and mainly includes surgery. This clinic offers cryoneurolysis routinely to spastic patients to manage their severe spasticity, contracture and associated pain. In this observational project, the outcomes after cryoneurolysis in patients with wrist and hand contracture will be studied systematically and with more details to determine any changes in pain and range of motion after this procedure.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 9, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 1, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 25, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

October 3, 2023

Status Verified

September 1, 2023

Enrollment Period

1.4 years

First QC Date

August 1, 2023

Last Update Submit

September 28, 2023

Conditions

Keywords

Wrist contractureSevere spasticityPainCryoneurolysisHand contracture

Outcome Measures

Primary Outcomes (4)

  • Any changes in wrist and hand pain after cryoneurolysis.

    The intensity of pain in wrist and hand area will be measured based on numerical rating scale (NRS) on scale of 0 to 10 (0 means no pain at all and 10 shows the worst pain that the patient reports).

    The assessment will be done at baseline, 2 weeks, 1 and 4 months after the procedure.

  • Any changes in wrist and hand pain after cryoneurolysis , in patients who are not cognitively able to report the intensity of pain.

    Patients who cognitively are not able to score their pain based on NRS, will be assessed by checklist of nonverbal pain indicators (CNPI). In this scale the patients will be observed in rest and during any movement, and any non verbal or verbal complaints, facial grimaces, bracing, restlessness, rubbing of the affected area will be recorded. The presence or absence of these symptoms will be recorded.

    The assessment will be done at baseline, 2 weeks, 1 and 4 months after the procedure.

  • Any changes in wrist and hand spasticity and tone.

    The degree of spasticity will be measured based on Modified Ashworth Scale (MAS) . This scale has 6 scores from 0 which means no spasticity to 4 which means the maximum tone in which the limb movement is limited.

    The assessment will be done at baseline, 2 weeks, one and four months after the procedure.

  • Any changes in wrist and hand range of motion will be recorded.

    Maximum passive and active range of motion of wrist , second and fifth metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints and thumb radial and palmar abduction will be measured using a goniometer.

    The assessment will be done at baseline, 2 weeks, one and four months after the procedure.

Secondary Outcomes (3)

  • Any changes in maximum distance between pulp of the fingers and palm of the hand.

    The assessment will be done at baseline, 2 weeks, one and four months after the procedure.

  • Any changes in hand hygiene will be recorded.

    The assessment will be done at baseline, 2 weeks, one and four months after the procedure.

  • Patients satisfaction on pre set goals, after the procedure.

    The assessment will be done at baseline and at 4 months.

Study Arms (1)

Case group

Any adult patient with severe hand and wrist spasticity or contracture who suffers from a refractory pain, and is already candidate for cryoneurolysis.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any adult patient with wrist/hand contracture and a refractory pain who is already a candidate for cryoneurolysis based on their response to the diagnostic nerve block test (DNB).

You may qualify if:

  • Adult patients(at least 18 years old).
  • Severe claw hand with less than 4 cm distance between the pulp of the fingers and palm of the hand.
  • MAS\>= 3 in wrist and hand muscles interfering with function or causing a clinical problem, due to any neurological condition.
  • Have refractory pain in wrist and hand areas with no response to the usual pain management methods including oral medication or botulinum toxin injection.
  • Patients are already candidate for cryoneurolysis to manage the pain and spasticity in their hand and wrist, based on their response to diagnostic nerve block test (DNB).
  • Ability to attend testing sessions, comply with testing protocols and provide written informed consent. For patients who physically are not able to complete the consent process, a witness may be asked to sign and confirm their willing for participation. Legal representative may be asked to help with consent process for participants who cognitively are not able to consent on their behalf.

You may not qualify if:

  • Have undergone any previous peripheral nerve procedures in their affected side, for the treatment of spasticity, including previous cryoneurolysis, chemical neurolysis, neurectomy or arthroplasty.
  • Patients who received botulinum toxin in past 4 months in the same targeted muscles for cryoneurolysis, however, they may enter the study at the 4-month mark.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Victoria General Hospital

Victoria, British Columbia, V8Z 6R5, Canada

RECRUITING

Related Publications (5)

  • Clavet H, Hebert PC, Fergusson D, Doucette S, Trudel G. Joint contracture following prolonged stay in the intensive care unit. CMAJ. 2008 Mar 11;178(6):691-7. doi: 10.1503/cmaj.071056.

    PMID: 18332384BACKGROUND
  • Diong J, Harvey LA, Kwah LK, Eyles J, Ling MJ, Ben M, Herbert RD. Incidence and predictors of contracture after spinal cord injury--a prospective cohort study. Spinal Cord. 2012 Aug;50(8):579-84. doi: 10.1038/sc.2012.25. Epub 2012 Mar 27.

    PMID: 22450888BACKGROUND
  • Matozinho CVO, Teixeira-Salmela LF, Samora GAR, Sant'Anna R, Faria CDCM, Scianni A. Incidence and potential predictors of early onset of upper-limb contractures after stroke. Disabil Rehabil. 2021 Mar;43(5):678-684. doi: 10.1080/09638288.2019.1637949. Epub 2019 Jul 22.

    PMID: 31328966BACKGROUND
  • Schnitzler A, Diebold A, Parratte B, Tliba L, Genet F, Denormandie P. An alternative treatment for contractures of the elderly institutionalized persons: Microinvasive percutaneous needle tenotomy of the finger flexors. Ann Phys Rehabil Med. 2016 Apr;59(2):83-6. doi: 10.1016/j.rehab.2015.11.005. Epub 2016 Jan 13.

    PMID: 26797076BACKGROUND
  • Ilfeld BM, Gabriel RA, Trescot AM. Ultrasound-guided percutaneous cryoneurolysis for treatment of acute pain: could cryoanalgesia replace continuous peripheral nerve blocks? Br J Anaesth. 2017 Oct 1;119(4):703-706. doi: 10.1093/bja/aex142. No abstract available.

    PMID: 29121277BACKGROUND

MeSH Terms

Conditions

ContractureMuscle SpasticityPain

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesMuscular DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Paul Winston, MD

    Vancouver Island Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2023

First Posted

September 25, 2023

Study Start

January 9, 2023

Primary Completion

June 1, 2024

Study Completion

September 1, 2024

Last Updated

October 3, 2023

Record last verified: 2023-09

Locations